122 related articles for article (PubMed ID: 28503870)
1. Correcting hazard ratio estimates for outcome misclassification using multiple imputation with internal validation data.
Ni J; Leong A; Dasgupta K; Rahme E
Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):925-934. PubMed ID: 28503870
[TBL] [Abstract][Full Text] [Related]
2. Comparing external and internal validation methods in correcting outcome misclassification bias in logistic regression: A simulation study and application to the case of postsurgical venous thromboembolism following total hip and knee arthroplasty.
Ni J; Dasgupta K; Kahn SR; Talbot D; Lefebvre G; Lix LM; Berry G; Burman M; Dimentberg R; Laflamme Y; Cirkovic A; Rahme E
Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):217-226. PubMed ID: 30515908
[TBL] [Abstract][Full Text] [Related]
3. Effects of expanding the look-back period to all available data in the assessment of covariates.
Nakasian SS; Rassen JA; Franklin JM
Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):890-899. PubMed ID: 28397352
[TBL] [Abstract][Full Text] [Related]
4. Statin-associated incident diabetes: a literature review.
Park ZH; Juska A; Dyakov D; Patel RV
Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
[TBL] [Abstract][Full Text] [Related]
5. Statin Use and the Risk for Incident Diabetes Mellitus in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Population-Based Retrospective Cohort Study in Taiwan.
Lin ZF; Wang CY; Shen LJ; Hsiao FY; Lin Wu FL
Can J Diabetes; 2016 Jun; 40(3):264-9. PubMed ID: 26992286
[TBL] [Abstract][Full Text] [Related]
6. Lipid-lowering drugs and risk of new-onset diabetes: a cohort study using Japanese healthcare data linked to clinical data for health screening.
Ooba N; Setoguchi S; Sato T; Kubota K
BMJ Open; 2017 Jun; 7(6):e015935. PubMed ID: 28667223
[TBL] [Abstract][Full Text] [Related]
7. Statins, risk of diabetes, and implications on outcomes in the general population.
Wang KL; Liu CJ; Chao TF; Huang CM; Wu CH; Chen SJ; Chen TJ; Lin SJ; Chiang CE
J Am Coll Cardiol; 2012 Oct; 60(14):1231-8. PubMed ID: 22884288
[TBL] [Abstract][Full Text] [Related]
8. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
Nichols GA; Koro CE
Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
[TBL] [Abstract][Full Text] [Related]
9. Statin Use, Diabetes Incidence and Overall Mortality in Normoglycemic and Impaired Fasting Glucose Patients.
Castro MR; Simon G; Cha SS; Yawn BP; Melton LJ; Caraballo PJ
J Gen Intern Med; 2016 May; 31(5):502-8. PubMed ID: 26850412
[TBL] [Abstract][Full Text] [Related]
10. Risk Factor for Diabetes Mellitus and High Blood Glucose With HMG-CoA Reductase Inhibitors Using a Postmarketing Surveillance Database in Japan.
Hashiguchi M; Maruyama J; Shimizu M; Takahashi D; Shiga T
Clin Pharmacol Drug Dev; 2018 Nov; 7(8):800-810. PubMed ID: 29462515
[TBL] [Abstract][Full Text] [Related]
11. A comparison of sensitivity-specificity imputation, direct imputation and fully Bayesian analysis to adjust for exposure misclassification when validation data are unavailable.
Corbin M; Haslett S; Pearce N; Maule M; Greenland S
Int J Epidemiol; 2017 Jun; 46(3):1063-1072. PubMed ID: 28338966
[TBL] [Abstract][Full Text] [Related]
12. Improved Correction of Misclassification Bias With Bootstrap Imputation.
van Walraven C
Med Care; 2018 Jul; 56(7):e39-e45. PubMed ID: 28787347
[TBL] [Abstract][Full Text] [Related]
13. Risk of new-onset diabetes mellitus versus reduction in cardiovascular events with statin therapy.
Wang KL; Liu CJ; Chao TF; Chen SJ; Wu CH; Huang CM; Chang CC; Wang KF; Chen TJ; Lin SJ; Chiang CE
Am J Cardiol; 2014 Feb; 113(4):631-6. PubMed ID: 24360773
[TBL] [Abstract][Full Text] [Related]
14. Statin use and risk of new-onset diabetes: A meta-analysis of observational studies.
Casula M; Mozzanica F; Scotti L; Tragni E; Pirillo A; Corrao G; Catapano AL
Nutr Metab Cardiovasc Dis; 2017 May; 27(5):396-406. PubMed ID: 28416099
[TBL] [Abstract][Full Text] [Related]
15. Estimating the population prevalence of diagnosed and undiagnosed diabetes.
Leong A; Dasgupta K; Chiasson JL; Rahme E
Diabetes Care; 2013 Oct; 36(10):3002-8. PubMed ID: 23656982
[TBL] [Abstract][Full Text] [Related]
16. Risk of diabetes in patients treated with HMG-CoA reductase inhibitors.
Cho Y; Choe E; Lee YH; Seo JW; Choi Y; Yun Y; Wang HJ; Ahn CW; Cha BS; Lee HC; Kang ES
Metabolism; 2015 Apr; 64(4):482-8. PubMed ID: 25312577
[TBL] [Abstract][Full Text] [Related]
17. Approach to addressing missing data for electronic medical records and pharmacy claims data research.
Bounthavong M; Watanabe JH; Sullivan KM
Pharmacotherapy; 2015 Apr; 35(4):380-7. PubMed ID: 25884526
[TBL] [Abstract][Full Text] [Related]
18. Statin therapy is associated with the development of new-onset diabetes after transplantation in liver recipients with high fasting plasma glucose levels.
Cho Y; Lee MJ; Choe EY; Jung CH; Joo DJ; Kim MS; Cha BS; Park JY; Kang ES
Liver Transpl; 2014 May; 20(5):557-63. PubMed ID: 24477986
[TBL] [Abstract][Full Text] [Related]
19. Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease.
Chang CH; Lee YC; Tsai CT; Chang SN; Chung YH; Lin MS; Lin JW; Lai MS
Atherosclerosis; 2014 Jan; 232(1):224-30. PubMed ID: 24401243
[TBL] [Abstract][Full Text] [Related]
20. Methods for using clinical laboratory test results as baseline confounders in multi-site observational database studies when missing data are expected.
Raebel MA; Shetterly S; Lu CY; Flory J; Gagne JJ; Harrell FE; Haynes K; Herrinton LJ; Patorno E; Popovic J; Selvan M; Shoaibi A; Wang X; Roy J
Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):798-814. PubMed ID: 27146273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
